Argis İlaç achieved high rankings in Turkishtime magazine’s 2021 R&D survey, continuing its performance in previous years.
Argis İlaç ranked 29th in the Top 250 Companies by R&D Expenditure list and third among pharmaceutical companies.
In the Top 100 by Number of Projects Carried Out at R&D Centres list, it ranked tenth overall and second among pharmaceutical companies.
We continue our R&D activities.
